Journal of Pharmaceutical Policy and Practice (Dec 2015)
Reimbursement policy optimization for Angiotensin-converting enzyme (ACE) inhibitors in Bulgaria: Controlling expenditure without undermining access to treatment
Abstract
No abstracts available.Keywords